June 3, 2020
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Tim Buchmiller
Re: | Acer Therapeutics Inc. |
Registration Statement on Form S-1, as amended
File No. 333-238192
Request for Acceleration of Effectiveness
Ladies and Gentlemen:
Pursuant to Rule 461 of the Securities Act of 1933, as amended, Acer Therapeutics Inc. hereby requests that the effective date of the above-captioned registration statement on Form S-1 (as amended, the “Registration Statement”) be accelerated so that the Registration Statement will become effective at 4:00 p.m., Eastern Time, on Thursday, June 4, 2020, or as soon thereafter as may be practicable.
Very truly yours,
ACER THERAPEUTICS INC.
/s/ Harry S. Palmin
Harry S. Palmin
Chief Operating Officer and
Chief Financial Officer
cc: | Mike Hird, Esq. |
Patty M. DeGaetano, Esq.
One Gateway Center, Suite 351, 300 Washington Street, Newton, MA 02458
Phone: (844) 902-6100